Loading viewer...
investor_presentation
Format: PDF investor_presentation
1 SMA Solar Technology SMA SOLAR TECHNOLOGY AG Analyst / Investor Presentation Financial Results 2023 Presented by Barbara Gregor, CFO & Jürgen Reinert, CEO March 27 , 2024
1 SMA Solar Technology
SMA SOLAR TECHNOLOGY AG
Analyst / Investor Presentation
Financial Results 2023
Presented by Barbara Gregor, CFO & Jürgen Reinert, CEO
March 27 , 20242 SMA Solar Technology
IMPORTANT LEGAL NOTICE
This presentation does not constitute or form part of, and should not be construed as, an offer or invitation to subscribe fo r, underwrite or otherwise acquire, any securities of
SMA Solar Technology AG (the "Company") or any present or future subsidiary of the Company (together with the Company, the "S MA Group") nor should it or any part of
it form the basis of, or be relied upon in connection with, any contract to purchase or subscribe for any securities in the C ompany or any member of the SMA Group or
commitment whatsoever.
All information contained herein has been carefully prepared. Nevertheless, we do not guarantee its accuracy or completeness andnothing herein shall be construed to be a
representation of such guarantee. The Company shall assume no liability for errors contained in this document, unless damages are caused intentionally or through gross
negligence by the Company. Furthermore, the Company shall assume no liability for effects of activities that evolve from the basis of data and information provided by this
The information contained in this presentation is subject to amendment, revision and updating, which does not underlie any pr iorannouncement by the Company. Certain
statements contained in this presentation may be statements of future expectations and other forward -looking statements that are based on the management's current views
and assumptions and involve known and unknown risks and uncertainties. Actual results, performance or events may differ mater ially from those in such statements as a result
of, among others, factors, changing business or other market conditions and the prospects for growth anticipated by the manag ement of the Company. These and other
factors could adversely affect the outcome and financial effects of the plans and events described herein. The Company does n ot undertake any obligation to update or
revise any forward -looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward -looking statements
which speak only as of the date of this presentation.
This presentation is for information purposes only and may not be further distributed or passed on to any party which is not theaddressee of this presentation solely after
prior consent of the Company. No part of this presentation must be copied, reproduced or cited by the addressees hereof other than for the purpose for which it has been
provided to the addressee. The content of this presentation, meaning all texts, pictures and sounds, are protected by copyrig ht.The contained information of the presentation
is property of the Company.
Preview truncated — download the full document for the complete content.
earnings
30 Pages
investor_presentation
32 Pages
Halozyme Therapeutics